Medicare Enrolled
Dr. Paul Schulman, M.D.
Rheumatology · Smithtown, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schulman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schulman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schulman
Dr. Paul Schulman is a rheumatology specialist in Smithtown, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schulman performed 122,473 Medicare services across 2,760 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schulman received a total of $68,199 from 48 pharmaceutical and/or device companies across 1087 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schulman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in NY
$68,199 industry payments
Medicare Practice Summary
Medicare Utilization ↗122,473
Medicare services
Top 3% in NY for rheumatology
2,760
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,124 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
47,800 | $4 | $11 |
| Tocilizumab injection (Actemra) | 29,229 | $5 | $7 |
| Denosumab injection (Prolia/Xgeva) | 12,240 | $18 | $32 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,150 | $34 | $70 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
10,751 | $11 | $50 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,510 | $26 | $150 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
2,100 | $63 | $112 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
1,560 | $13 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,319 | $108 | $175 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
611 | $1 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
564 | $8 | $17 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
451 | $70 | $250 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
373 | $0 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
358 | $122 | $581 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
189 | $74 | $192 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
181 | $26 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
167 | $71 | $125 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
152 | $4 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
150 | $8 | $30 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
131 | $58 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $145 | $360 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
80 | $7 | $60 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
52 | $46 | $325 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $13 | $50 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
30 | $51 | $160 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
30 | $32 | $75 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
28 | $4 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
26 | $59 | $175 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $36 | $80 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
20 | $27 | $75 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
18 | $31 | $75 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
17 | $35 | $75 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
15 | $25 | $75 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
14 | $45 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.5% high complexity
77.3% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$68,199
Total received (2018-2024)
Avg $9,743/year across 7 years
Top 9% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,087
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,632 (66.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,091 (32.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$476 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,557
2023
$5,848
2022
$4,304
2021
$6,815
2020
$18,584
2019
$11,292
2018
$17,799
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$724
ABBVIE INC.
$500
Janssen Biotech, Inc.
$465
PFIZER INC.
$347
Lilly USA, LLC
$320
UCB, Inc.
$276
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
GlaxoSmithKline, LLC.
$163
Novartis Pharmaceuticals Corporation
$120
Aurinia Pharma U.S., Inc.
$68
Sandoz Inc.
$64
Kiniksa Pharmaceuticals International, plc
$45
Radius Health, Inc.
$44
Ferring Pharmaceuticals Inc.
$44
Genentech USA, Inc.
$35
Fidia Pharma USA Inc.
$31
SOBI, INC
$30
E.R. Squibb & Sons, L.L.C.
$29
AstraZeneca Pharmaceuticals LP
$21
Alexion Pharmaceuticals, Inc.
$20
Top 3 companies account for 47.5% of 2024 payments
All-time payments by company (2018-2024) ›
United Rheumatology
$44,232
Amgen Inc.
$3,708
AbbVie Inc.
$2,146
PFIZER INC.
$2,062
Janssen Biotech, Inc.
$2,015
ABBVIE INC.
$1,835
Lilly USA, LLC
$1,551
Fresenius Kabi USA, LLC
$1,400
UCB, Inc.
$1,311
Horizon Therapeutics plc
$863
Novartis Pharmaceuticals Corporation
$799
Genentech USA, Inc.
$664
GlaxoSmithKline, LLC.
$629
AstraZeneca Pharmaceuticals LP
$572
Radius Health, Inc.
$507
Boehringer Ingelheim Pharmaceuticals, Inc.
$459
AbbVie, Inc.
$450
Aurinia Pharma U.S., Inc.
$393
Regeneron Healthcare Solutions, Inc.
$388
Fidia Pharma USA Inc.
$334
Ferring Pharmaceuticals Inc.
$225
Pacira Therapeutics, Inc.
$186
Mallinckrodt Enterprises LLC
$158
Mallinckrodt Hospital Products Inc.
$148
Mallinckrodt LLC
$112
MEDAC PHARMA, INC.
$110
DePuy Synthes Sales Inc.
$107
Celgene Corporation
$81
Sandoz Inc.
$78
ANI Pharmaceuticals, Inc.
$66
Flexion Therapeutics, Inc.
$64
Antares Pharma, Inc.
$63
Merck Sharp & Dohme Corporation
$62
Horizon Pharma plc
$48
Kiniksa Pharmaceuticals International, plc
$45
E.R. Squibb & Sons, L.L.C.
$40
West-Ward Pharmaceuticals
$36
SOBI, INC
$30
Hikma Pharmaceuticals USA
$28
Exeltis, USA Inc.
$27
Kiniksa Pharmaceuticals, Ltd.
$24
Sobi, Inc
$24
Actelion Pharmaceuticals US, Inc.
$24
GENZYME CORPORATION
$22
Alexion Pharmaceuticals, Inc.
$20
GRT US Holding, Inc.
$20
FIDIA PHARMA USA INC.
$18
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 73.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYALGAN · HYM/HYN · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for rheumatology in NY.
Geographic Context
Rheumatologists within 10 mi
60
Per 100K population
3.9
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schulman is a mixed practice specialist, with above-average Medicare volume (top 3% in NY), with consulting-driven industry engagement in the top 9% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schulman experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Schulman performed 47,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schulman receive payments from pharmaceutical companies?
Yes. Dr. Schulman received a total of $68,199 from 48 companies across 1,087 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schulman's costs compare to other rheumatologists in Smithtown?
Dr. Schulman's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schulman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Smithtown
Browse rheumatologists in Smithtown ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
United Rheumatology Payments to Doctors
See all physicians who received payments from United Rheumatology.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology